Aggredyne
Houston, Texas, United States
About Aggredyne
Aggredyne, Inc. (www.aggredyne.com), is a biomedical company founded in 2011 by Edward R. Teitel, MD, JD, and Robert C. Hux, CPA, to commercialize the AggreGuideTM platelet function analyzer. The AggreGuide system is an in-vitro diagnostic test that measures how sticky a patient’s platelets are and how well the patient is responding to antiplatelet medications such as aspirin or Plavix® (clopidogrel), Effient® (prasugrel) and Brillinta® (ticagrelor).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $3.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2012)
- Website: aggredyne.com
- Phone: 713-636-5996
Industries & Categories
Biotechnology, Health Diagnostics, Therapeutics
Canonical: https://fsome.com/organization/aggredyne-2581839 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.